VTv Accounts Payable from 2010 to 2025

VTVT Stock  USD 17.20  0.17  0.98%   
VTv Therapeutics Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable will likely drop to about 892 K in 2025. Accounts Payable is the amount vTv Therapeutics owes to suppliers or vendors for products or services received but not yet paid for. It represents VTv Therapeutics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2013-12-31
Previous Quarter
6.8 M
Current Value
939 K
Quarterly Volatility
3.4 M
 
Yuan Drop
 
Covid
Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 84.5 K, Interest Expense of 0.0 or Selling General Administrative of 11.8 M, as well as many indicators such as Price To Sales Ratio of 68.57, Dividend Yield of 0.0 or PTB Ratio of 6.86. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.
  
Check out the analysis of VTv Therapeutics Correlation against competitors.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

Latest VTv Therapeutics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of vTv Therapeutics over the last few years. An accounting item on the balance sheet that represents VTv Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of vTv Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. VTv Therapeutics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

VTv Accounts Payable Regression Statistics

Arithmetic Mean5,109,941
Geometric Mean3,899,553
Coefficient Of Variation72.08
Mean Deviation2,755,162
Median4,835,000
Standard Deviation3,683,224
Sample Variance13.6T
Range13M
R-Value(0.37)
Mean Square Error12.6T
R-Squared0.13
Significance0.16
Slope(282,574)
Total Sum of Squares203.5T

VTv Accounts Payable History

2025892 K
2024939 K
20234.1 M
20222.5 M
20211.9 M
20201.9 M
20197.1 M

About VTv Therapeutics Financial Statements

VTv Therapeutics shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in VTv Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on VTv Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable939 K892 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VTv Stock Analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.